The study of neurodegenerative diseases delves into the intricate processes of neuronal decline and dysfunction, exploring the mechanisms behind disorders like amyotrophic lateral sclerosis, multiple sclerosis, and frontotemporal dementia. Cutting-edge research highlights the role of protein misfolding, mitochondrial dysfunction, and neuroinflammation in disease pathology. Therapies targeting these pathways, including small molecules, gene therapies, and stem cell-based treatments, are at the forefront of clinical trials. Efforts to integrate neuroimaging and computational models enhance the understanding of disease progression, enabling the design of precise therapeutic interventions. Collaborative advancements are reshaping the future of managing and potentially reversing the effects of these complex disorders.
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : In silico in vitro and in vivo study of geraniol role in Alzheimer's disease
Bhuvanesh Baniya, Mohanlal Sukhadia University, India
Title : Prince transform: a wave-mechanical framework for real-time EEG analysis and early seizure prediction using chirp and drift detection
Mustafa A Khan, Sevaro Health Inc., United States
Title : Gut-brain axis in autism spectrum disorder: MicroRNAs as a critical mediator of pathogenesis
Rahem Rahmati, Shahrekord University of Medical Sciences, Iran (Islamic Republic of)